| K-number | K181334 |
| Device name | ADVIA Centaur Herpes-2 IgG |
| Applicant | Biokit, S.A. |
| Product code | MYF |
| Device class | Class II |
| Decision date | Aug 23, 2018 |
| Decision | Substantially Equivalent |
| Regulation | 866.3305 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov